title: Which factors affect the occurrence of severe cerebral lesions in preterm neonates who are born with intrauterine infection?
abstract: OBJECTIVE
  The purpose of this study was to evaluate which factors affect the occurrence of neonatal ultrasonographic evidence of severe cerebral lesions in the presence of intrauterine infection.
  
  
  METHODS
  From a cohort of 567 singleton neonates who were born between 24.0 and 31.6 weeks of gestation, we identified the 180 infants with histologic and/or clinical evidence of intrauterine infection. We excluded stillbirths and congenital anomalies. Obstetric and neonatal variables were related to evidence of severe neonatal ultrasonographic cerebral lesions with the use of logistic regression analysis.
  
  
  RESULTS
  Severe cerebral lesions were identified in 10% of infants (18/180). After we controlled for variables that were clinically relevant, logistic regression analysis demonstrated that ultrasound evidence of severe neonatal cerebral lesions was associated independently with antenatal administration of corticosteroids (adjusted odds ratio, 0.3; 95% CI, 0.11-0.88; P = .03) and occurrence of placental abruption (adjusted odds ratio, 5.4; 95% CI, 1.4-20.7; P = .02).
  
  
  CONCLUSIONS
  Antenatal administration of corticosteroids in the presence of intrauterine infection has a protective effect on the risk of ultrasonographic evidence of severe neonatal cerebral lesions.
authors.affiliation: Department of Obstetrics and Gynecology, University of Milano-Bicocca, Monza, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Locatelli
authors.forename: Alessandro
authors.initials: A
authors.lastname: Ghidini
authors.forename: Francesca
authors.initials: F
authors.lastname: Assi
authors.forename: Marianna
authors.initials: M
authors.lastname: Andreani
authors.forename: Silvia
authors.initials: S
authors.lastname: Malguzzi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Paterlini
mesh_terms: D000328:Adult; D002821:Chorioamnionitis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007969:Leukomalacia, Periventricular / Q000000981:diagnostic imaging / Q000453:epidemiology*; D011247:Pregnancy; D011256:Pregnancy Outcome; D012307:Risk Factors; D014463:Ultrasonography